The results from our mdARA indicate that, in particular, larger vessels that are co-opted by the tumor could continue to provide the tumor with new vessels for expansive growth and increasing the nutritional demands under VEGF-targeted therapy. The gene discussed is VEGFA; the disease is neoplasm.